Abstract
Introduction/BackgroundMore than 80% of patients with advanced ovarian cancer present with recurrence within five years. During the last decades, Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy has been introduced as a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have